India  

Johnson & Johnson

U.S. multinational medical manufacturer

Johnson & Johnson    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Johnson & Johnson: U.S. multinational medical manufacturer
Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.

0
shares
ShareTweetSavePostSend
 

Johnson & Johnson is splitting into two companies [Video]

Johnson & Johnson is splitting into two companies

Johnson & Johnson is separating the consumer health products part of the business from the prescription drugs and medical devices unit. CNN’s Paul R. La Monica reports.

Credit: Bleacher Report AOL     Duration: 01:29Published
Man with rare condition after J&J vaccine wants people to get vaccinated [Video]

Man with rare condition after J&J vaccine wants people to get vaccinated

Anthony Flint, who claims to have developed Guillain-Barré syndrome after his Johnson & Johnson Covid-19 vaccination, discusses the rare autoimmune disorder and why he is still urging others to get..

Credit: Bleacher Report AOL     Duration: 04:00Published
FDA to vote on J&J COVID-19 booster shoots; also looking into mixing and matching vaccine doses [Video]

FDA to vote on J&J COVID-19 booster shoots; also looking into mixing and matching vaccine doses

On Friday, the Food and Drug Administration Advisory Committee will review safety and efficacy data to see if they should expand Johnson & Johnson's emergency use authorization to include a booster..

Credit: ABC Action News     Duration: 02:13Published

You Might Like


India set to get first J&J Covid vaccine doses in October, says source

India expects to get its first Johnson & Johnson Covid-19 vaccine doses from next month, filled and finished in India by a partner of the US drugmaker, a source with knowledge of the matter told..
IndiaTimes - Published

‘J&J should prioritise supply of locally-made Covid-19 jabs to India’


IndiaTimes - Published

Johnson & Johnson's single-shot vaccine likely to be rolled out in India by October

Johnson & Johnson's single-shot vaccine was the fifth vaccine to get Emergency Use Approval for use in India by Drug Controller General on August 7.
DNA - Published

Johnson and Johnson seeks nod to study Covid-19 vaccine among kids in India


IndiaTimes - Published

Covid-19: Johnson & Johnson seeks approval to conduct vaccine trials for 12-17 age group

Johnson & Johnson has submitted an application to the central drugs standard control organisation (CDSCO) to conduct a study of its Covid-19 vaccine in India in adolescents aged 12-17 years.
IndiaTimes - Published

Johnson & Johnson's single-dose Covid vax gets emergency use nod


IndiaTimes - Published Also reported by •DNA

Johnson and Johnson’s Covid-19 vaccine gets nod for emergency use in India

India has approved Johnson & Johnson's single-dose CoviD-19 vaccine for emergency use on Saturday, health minister Mansukh Mandaviya said in a tweet. This will further boost the country's collective..
IndiaTimes - Published Also reported by •DNA

Johnson & Johnson applies for Emergency Use Authorization of its single-dose Covid vaccine in India

Johnson & Johnson has applied for Emergency Use Authorization (EUA) of its single-dose Covid-19 vaccine in India, the global healthcare major said on Friday.
IndiaTimes - Published Also reported by •DNA

J&J withdraws plea to hold vaccine trials as govt relaxes norms


IndiaTimes - Published

'J&J withdraws proposal for speedy vaccine approval in India'


IndiaTimes - Published

Ben Crump Sues J&J Over 'Cancerous' Talcum Powder Targeted at Black Women

Ben Crump is suing Johnson & Johnson for allegedly targeting Black women with a product he says has been linked to cancer -- and it sounds like they're going class action with this. The civil rights..
TMZ.com - Published

Indemnity issue holds up J&J, Pfizer and Moderna jabs


IndiaTimes - Published

Covid-19: Wrong injection technique could also be leading to clots

A new study shows that wrong injection technique could be one of the reasons behind clotting following inoculation by adeno virus-based Covid vaccines, which include AstraZeneca, J&J and Sputnik jabs...
IndiaTimes - Published

Covid-19: Govt talking to J&J over single-dose jab

The government is in talks with Johnson & Johnson regarding their single-dose vaccine and as per the plan, this vaccine will also be produced by Hyderabad's Biological E, NITI Aayog member-health Dr V..
IndiaTimes - Published

India to get Johnson & Johnson's single-dose COVID-19 vaccine soon?

Appreciating the Janssen vaccine, Dr VK Paul said, "It is a good single-dose vaccine. Single doses can be used to complete the full course."
DNA - Published

Discussions on to speed up vaccine delivery: J&J


IndiaTimes - Published

J&J explores ways to speed up delivery of its Covid-19 vaccine in India

Johnson & Johnson (J&J) said on Tuesday it was in talks with the Indian government to explore ways to speed up delivery of its single-shot Covid-19 vaccine in the country. The Economic Times newspaper..
IndiaTimes - Published

Johnson & Johnson COVID-19 vaccine likely to be available in India by July - price and other details here

The efficacy of the vaccine developed by Johnson and Johnson is 66.3% for mild to moderate COVID-19 and 76.3% for severe to critical infection.
DNA - Published

Moderna offers to sell booster shots from January; indemnity-waiver talks on

US vaccine maker Moderna has offered to sell booster doses of its Covid vaccine to India, from January 2022 even as the government continues to hold negotiations with Moderna and J&J on the indemnity..
IndiaTimes - Published

India in talks with Pfizer, J&J, Moderna for local manufacturing of COVID vaccines: Harsh Vardhan Shringla

Last month saw India getting the first batches of Suptink V vaccines, which will be also produced by Indian companies.
DNA - Published

US Supreme Court rejects Johnson & Johnson appeal of $2bn talc verdict

us supreme court rejects johnson & johnson appeal of $2bn talc verdict
The US Supreme Court has declined to hear Johnson & Johnson's appeal against a $2.12bn (£1.5bn) damages award to women who say they developed ovarian cancer from using the company's talc products.
Sky News - Published

How does the newly-approved Johnson & Johnson COVID vaccine work - and how does it compare?

how does the newly-approved johnson & johnson covid vaccine work - and how does it compare?
The Johnson & Johnson (J&J) vaccine is the fourth coronavirus jab approved for use in the UK.
Sky News - Published

Johnson & Johnson single-dose vaccine approved for use in the UK

The Johnson & Johnson single-dose coronavirus vaccine has been approved for use in the UK, the medicines regulator has said.
Sky News - Published

Govt looking into securing part of Johnson & Johnson vaccines for Indian market: Sources


IndiaTimes - Published

Anti-Vaxxer Steals COVID Vaccine Vials in Bizarre Confrontation

An anti-vaxxer has been going around stealing vials of the Johnson & Johnson COVID vaccine, proclaiming it poisonous and urging people to turn their backs on it. It's a bizarre story. A guy named..
TMZ.com - Published

US panel recommends resuming Johnson & Johnson COVID-19 vaccine

us panel recommends resuming johnson & johnson covid-19 vaccine
A US medical panel has recommended resuming the use of the Johnson & Johnson COVID-19 vaccine.
Sky News - Published

Johnson & Johnson's Covid vaccine expected to be imported by June-July: Science and technology ministry


IndiaTimes - Published

Johnson & Johnson COVID vaccine could be linked to rare blood clots, EU regulator says

The European Medicines Agency says it has found a possible link between the Johnson & Johnson COVID vaccine and very rare cases of unusual blood clots.
Sky News - Published

India paves way for foreign Covid-19 vaccines: Side effects, risks of Pfizer, Moderna, Sputnik, J&J


IndiaTimes - Published

Pfizer, J&J vaccine rollout in India could take a few months

US pharma giants Pfizer, Johnson & Johnson, and Novavax could be among the potential gainers from the government’s decision on Tuesday to fast-track approvals for foreign-produced Covid-19 vaccines..
IndiaTimes - Published

Covid-19 vaccine: Pfizer, J&J entry could still be months away

US pharma biggies Pfizer, Johnson & Johnson and Moderna could be amongst the potential gainers of the government’s decision to fast-track approvals for foreign-produced Covid-19 vaccines. While..
IndiaTimes - Published

India ​seeks imports of Covid vaccines as cases soar

India is to fast-track emergency approvals for Covid-19 vaccines that have been authorised by Western countries and Japan, paving the way for possible imports of Pfizer, Johnson & Johnson, and Moderna..
IndiaTimes - Published

European rollout of Johnson & Johnson COVID jab delayed as US officials investigate clots

The rollout of the Johnson & Johnson COVID vaccine across Europe has been delayed, while US officials have recommended a "pause" in the use of the jab as reports of blood clots are investigated.
Sky News - Published

US recommends 'pause' to Johnson & Johnson jab rollout over blood clot fears

us recommends 'pause' to johnson & johnson jab rollout over blood clot fears
The US Food and Drug Administration has recommended a "pause" to the rollout of the Johnson & Johnson COVID vaccine so it can investigate reports of blood clots.
Sky News - Published

J&J in talks to start bridging clinical study


IndiaTimes - Published

EU regulator reviewing possible links between Johnson & Johnson jab and blood clots

Europe's drugs regulator is reviewing possible links between blood clots and Johnson & Johnson's coronavirus vaccine.
Sky News - Published

Johnson & Johnson says in talks with Indian govt for trial of single-dose vaccine


IndiaTimes - Published

India to make J&J’s Covid vax as part of Quad initiative

India will manufacture the US-developed Johnson & Johnson’s single-dose Covid shot as part of the first Quad vaccine initiative. The project will be financed by Japan and the US, while Australia will..
IndiaTimes - Published

Johnson & Johnson's single-shot vaccine recommended by EU regulator

Johnson & Johnson's single-shot COVID vaccine has been recommended for conditional approval by the EU drugs regulator.
Sky News - Published

'It's one and done': Single-dose Johnson & Johnson COVID vaccine cleared in the US

'it's one and done': single-dose johnson & johnson covid vaccine cleared in the us
US regulators have approved Johnson & Johnson's single-dose COVID jab, enabling millions more Americans to be vaccinated and setting the vaccine up for additional approvals around the world.
Sky News - Published

Single-shot COVID vaccine from Johnson & Johnson up to 85% effective

single-shot covid vaccine from johnson & johnson up to 85% effective
A single-shot vaccine developed by the healthcare giant Johnson & Johnson is up to 85% effective in preventing the most serious coronavirus symptoms, according to data from mass trials.
Sky News - Published

Human trials begin in fortnight, J&J works to ramp up production of affordable Covid vaccine: Top scientist

Johnson & Johnson is preparing the ground for the entry of a vaccine against Covid-19 and is expanding its manufacturing capacity to supply more than one billion doses through 2021 in a not-for-profit..
IndiaTimes - Published

Johnson & Johnson in talks with governments on possible COVID-19 vaccine

Johnson & Johnson is in talks with multiple governments and global organizations as it seeks to develop a COVID-19 vaccine, it said on Thursday after Reuters reported that the U.S. company is in talks..
Reuters - Published

Exclusive: Europe to accelerate trials of gene-engineered COVID-19 vaccines - sources

European officials aim to speed up trials for coronavirus vaccines containing genetically modified organisms, two EU sources told Reuters, in a move that could help shots developed by companies like..
Reuters India - Published

Johnson & Johnson plans to start human trial of COVID-19 vaccine by Sept

The first batches of a COVID-19 vaccine could be available for emergency use authorisation in early 2021, the company said.
IndiaTimes - Published

Johnson & Johnson partners with U.S. agency to develop coronavirus vaccine

Johnson & Johnson said on Tuesday it was working with the Biomedical Advanced Research and Development Authority (BARDA) to speed up development of a coronavirus vaccine.
Reuters - Published


 Page 1  〉